Skip to main content
  • Marley, one of our Pet Heroes!
    Marley participated in a clinical trial for dogs with bone tumors, that ultimately could help humans with same disease.
  • Watch The Blue Buffalo Gift Announcement
    On Wednesday, May 18, Blue Buffalo Company announced a $6 million gift will advance clinical trials at College of Veterinary Med
  • Clinical Trials Office featured on FOX28
    Dr. Cheryl London discusses how research on pet osteosarcoma could someday help children with the same disease
  • Beloved Ohio Police K-9 joins clinical trial
    Nero Joins Clinical Trial after being diagnosed with B-cell lymphoma
  • Cheryl London - TEDxOhioStateUniversity
    Dr. Cheryl London talks about clinical trials in pets, and how they are more useful when adapting cancer treatments to humans.
  • Clinical Trials in Veterinary Medicine
    Learn about the purpose of clinical trials, benefits, risks, impact in humane medicine and more in this video.
  • Benefits of clinical trials
    Clinical trials have the potential to help not only your pet, but other pets with the same disease.

New Trials

Diagnosing and managing neuropathic pain in dogs with spinal cord injury (SCI). The purpose of this study to monitor dogs for the development of neuropathic pain after SCI, and to test medication effects and inter-observer agreement of a technique to quantify neuropathic pain. We will correlate these results with force plate data from dogs at the same visit.  
Correlation of plasma levels of a potential biomarker (CK-18) with diarrhea in dogs with mast cell tumor treated receiving toceranib (Palladia). -- The purpose of this pilot study is to determine if plasma CK18 levels can be used as a biomarker that can predict GI side effects in dogs receiving toceranib.
Evaluation of Allergenic Extract Intradermal Threshold Concentration Variation in Non-Allergic Dogs. -- The purpose of this study is to establish threshold concentrations of allergens by a new veterinary allergen company.

Pet Heroes

 

Norman, Mya and Finnegan enrolled into a trial last week for healthy dogs.